Can pharma innovate like a tech giant?
When it comes to digital disruption in healthcare, oncology, perhaps more than any other specialty, is changing the most. Dr Michelle Tempest and Roma...
The eyes have it
Dr Michelle Tempest and Patrick Bansch of bespoke health and social care strategy and investment consultancy Candesic get a close-up look of the private...
The DOLLAR$ in DIALYSIS
The dialysis market is highly consolidated but is there room for growth? Sam Coates, Gonçalo Silva and Dr Victor Chua of Mansfield Advisors assess...
Have baby, will travel
Despite huge medical advances over recent years, national policy on funding and access to fertility treatment varies widely from country to country. As regulation...
IVF – fertile ground for consolidation?
Despite recent private equity interest, IVF and fertility treatment remains a highly fragmented market but that could be about to change. Dr Leonid Shapiro,...
Healthcare real estate from the fringes to the core
Historically, healthcare has been a niche area of the real estate investment market in the UK but Tom Morgan, senior director, healthcare at CBRE,...
Out of the shadows
Child and adolescent mental health services are in crisis with some figures suggesting just 12.5% of those children in need are in contact with...
The chance to get personal
Consumers are increasingly paying for their own genetic profiles and becoming aware of their health risks but who will step in to help them...
What’s in a name?
As Harley Street’s international patient market faces increasing competition from old rivals and new challengers, The Howard de Walden
Estate has embarked on a strategy...
©2019 All rights reserved LaingBuisson 
